Idorsia, a Swiss biopharmaceutical company, was spun off following an acquisition by Johnson & Johnson from Actelion.
1 report, 1 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Idorsia, a Swiss biopharmaceutical company, was spun off following an acquisition by Johnson & Johnson from Actelion.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Idorsia
company in Allschwil, Switzerland
Nothing else this week.